These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 550980)

  • 1. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(1):49-52. PubMed ID: 550980
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic activity in coronary heart disease.
    Yao SK; Chen ZJ; Tao SQ
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonate versus ADP-induced platelet aggregation in acute myocardial infarction.
    Szczeklik A; Serwońska M; Lukasiewicz W; Mruk J; Musial J
    Thromb Haemost; 1979 Aug; 42(2):822-3. PubMed ID: 505390
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine diphosphate-induced platelet aggregation in the states of hypercoagulability.
    Wang TY; Hussey CV
    Ann Clin Lab Sci; 1977; 7(2):152-7. PubMed ID: 851349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrinolytic activity and coronary heart disease].
    Yao SK; Chen ZJ; Tao SQ
    Zhonghua Nei Ke Za Zhi; 1987 Feb; 26(2):71-3, 124. PubMed ID: 3608720
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro effects of rt-PA on platelet function and clot strength.
    D'Amico EA; Chamone DA; Bydlowski SP
    Thromb Res; 1997 Mar; 85(6):519-22. PubMed ID: 9101644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
    Krug H; Gryglik J; Jasiński K; Gluszek J
    Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional changes of platelet and its preservation during and after extracorporeal circulation (author's transl)].
    Isomura K
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Sep; 27(9):1235-49. PubMed ID: 501169
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet aggregation in portal cirrhosis.
    Ballard HS; Marcus AJ
    Arch Intern Med; 1976 Mar; 136(3):316-9. PubMed ID: 4041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of fibrinogens, FI and FII, to support ADP-induced platelet aggregation.
    Phillips HM; Mansouri A; Perry CA
    Thromb Haemost; 1983 Aug; 50(2):527-9. PubMed ID: 6636032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers.
    Pellegrini N; Pareti FI; Stabile F; Brusamolino A; Simonetti P
    Eur J Clin Nutr; 1996 Apr; 50(4):209-13. PubMed ID: 8730606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
    Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ADP-induced platelet aggregation by dipyrone in patients with acute myocardial infarction.
    Weinberger I; Joshua H; Friedmann J; Rahamim S; Agmon J
    Thromb Haemost; 1979 Aug; 42(2):752-6. PubMed ID: 505377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator inhibits aggregation of platelets in vitro.
    Mizuta T; Imai C
    Life Sci; 1988; 43(12):955-63. PubMed ID: 3139948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematological disorders in patients with gastric cancer].
    Yamamura T
    Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):675-85. PubMed ID: 6493191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
    Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 20. [Formation of left ventricular thrombus in acute myocardial infarction: significance of the determination of fibrinogen, of products of fibrinogen degradation, and of plasminogen].
    Perdigão C; Monteiro J; Nunes V; Varela MG; Geraldes MJ; Araújo A; Pais F; Ferreira D; Ribeiro C
    Rev Port Cardiol; 1992 Nov; 11(11):951-9. PubMed ID: 1290642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.